Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

European Medicines Agency Recommends Approval Of Alvotech's AVT06, A Proposed Biosimilar To Eylea, For Eye Disorders Across Europe

Author: Benzinga Newsdesk | June 23, 2025 04:40am

Posted In: ALVO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist